These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6344826)

  • 1. Glycosaminoglycan deposition in the acanthosis nigricans lesions of the polycystic ovary syndrome.
    Wortsman J; Matsuoka LY; Kupchella CE; Gavin JR; Dietrich JG
    Arch Intern Med; 1983 Jun; 143(6):1145-8. PubMed ID: 6344826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of endocrine abnormalities associated with acanthosis nigricans.
    Matsuoka LY; Wortsman J; Gavin JR; Goldman J
    Am J Med; 1987 Oct; 83(4):719-25. PubMed ID: 3674058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
    Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
    J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance with acanthosis nigricans and acral hypertrophy.
    Holdaway IM; Frengley PA; Graham FM; Wong M
    N Z Med J; 1984 May; 97(755):286-8. PubMed ID: 6587221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.
    Conway GS; Jacobs HS
    Postgrad Med J; 1990 Jul; 66(777):536-8. PubMed ID: 2217009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acanthosis nigricans, insulin resistance. Polycystic ovary syndrome and hypertrichosis].
    Mauduit G; Pugeat M; Chouvet B; El Baze P; Thivolet J
    Ann Dermatol Venereol; 1983; 110(9):737-8. PubMed ID: 6660778
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and endocrine profiles of 62 Malaysian women with polycystic ovary syndrome.
    Tan TT; Lui SK; Satgunasingam N; Khalid BA
    Med J Malaysia; 1989 Dec; 44(4):302-6. PubMed ID: 2520038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperandrogenism, insulin resistance and acanthosis nigricans. 10 years of progress.
    Barbieri RL
    J Reprod Med; 1994 May; 39(5):327-36. PubMed ID: 8064699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance).
    Moller DE; Flier JS
    N Engl J Med; 1988 Dec; 319(23):1526-9. PubMed ID: 2460770
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.
    Barbieri RL
    Am J Obstet Gynecol; 2000 Dec; 183(6):1412-8. PubMed ID: 11120504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of insulin resistance in subjects with acanthosis nigricans.
    Varthakavi PK; Patel KL; Wadhwa SL; Khopkar U; Sengupta RA; Merchant PC; Mehtalia SD; Nihalani KD
    J Assoc Physicians India; 2001 Jul; 49():705-12. PubMed ID: 11573555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans.
    Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF
    J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian pathology associated with insulin resistance and acanthosis nigricans.
    Annos T; Taymor ML
    Obstet Gynecol; 1981 Nov; 58(5):662-4. PubMed ID: 7301247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of insulin receptor abnormality (type A)].
    Kamada T; Horinosono M; Nishi M; Setoyama M; Oki T; Nagata Y; Arima T; Tashiro M; Otsuji S
    Igaku Kenkyu; 1992 Feb; 62(1):25-9. PubMed ID: 1523941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.
    Barbieri RL; Hornstein MD
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):685-703. PubMed ID: 3058472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index.
    Dong Z; Huang J; Huang L; Chen X; Yin Q; Yang D
    J Dermatol; 2013 Mar; 40(3):188-92. PubMed ID: 23289590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization.
    Dunaif A; Hoffman AR; Scully RE; Flier JS; Longcope C; Levy LJ; Crowley WF
    Obstet Gynecol; 1985 Oct; 66(4):545-52. PubMed ID: 3900841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The syndrome of acanthosis nigricans, hyperandrogenism and insulin resistance.
    Tatnall FM; Graham-Brown RA; Dandona P; Sarkany I
    Clin Exp Dermatol; 1984 Sep; 9(5):526-31. PubMed ID: 6488585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.